A pathological complete response by chemotherapy with S-1 and oxaliplatin for a locally advanced duodenal adenocarcinoma in Lynch syndrome: a case report

BACKGROUND: Although primary duodenal adenocarcinoma (DA) is a rare malignancy representing ~ 0.5% of all gastrointestinal cancers, the incidence of DA is more frequent in Lynch syndrome. Because of its rarity, treatment strategies or optimal chemotherapeutic regimens have not been clearly defined f...

Descripción completa

Detalles Bibliográficos
Autores principales: Yasuda, Satoshi, Harada, Suzuka, Tsujimoto, Akinori, Aoki, Satoko, Takei, Takeshi, Migita, Kazuhiro, Ueno, Masato, Tatsumi, Mitsutoshi, Watanabe, Akihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803604/
https://www.ncbi.nlm.nih.gov/pubmed/31637551
http://dx.doi.org/10.1186/s40792-019-0712-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803604/
https://www.ncbi.nlm.nih.gov/pubmed/31637551
http://dx.doi.org/10.1186/s40792-019-0712-8

Ejemplares similares